Stocks
Immunome (IMNM) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -24.4 | -36.3 | -28.0 | -151.4 | -209.4 | -233.3 | ||
| Changes by years, y/y, % | +43% | +48% | -23% | +441% | +38% | +65.2% | |||
Immunome. EBITDA US GAAP, bln rub
Immunome. EBITDA US GAAP, changes, %
Immunome. EBITDA US GAAP, sum by quarters, bln rub
Immunome (IMNM) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -43.9 | -42.7 | -56.9 | -69.1 | -53.1 | -233.3 | |
| Changes by years, y/y, % | +119% | +29% | +32% | +26% | +21% | |||
| Changes by quarters, q/q, % | -20% | -3% | +33% | +22% | -23% | |||
